Exact Mass: 466.3811

Exact Mass Matches: 466.3811

Found 261 metabolites which its exact mass value is equals to given mass value 466.3811, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Vitamin K1 2,3-epoxide

(1aS,7aR)-1a-methyl-7a-[(2E,7R,11R)-3,7,11,15-tetramethylhexadec-2-en-1-yl]-1aH,2H,7H,7aH-naphtho[2,3-b]oxirene-2,7-dione

C31H46O3 (466.3447)


Vitamin K1 2,3-epoxide (CAS: 25486-55-9) is a vitamin K derivative. Vitamin K is needed for the posttranslational modification of certain proteins, mostly required for blood coagulation. Within the cell, vitamin K undergoes electron reduction to a reduced form of vitamin K (called vitamin K hydroquinone) by the enzyme vitamin K epoxide reductase (or VKOR). Another enzyme then oxidizes vitamin K hydroquinone to allow carboxylation of glutamate into gamma-carboxyglutamate (Gla). This enzyme is called the gamma-glutamyl carboxylase or the vitamin K-dependent carboxylase. The carboxylation reaction will only proceed if the carboxylase enzyme is able to oxidize vitamin K hydroquinone into vitamin K epoxide at the same time; the carboxylation and epoxidation reactions are said to be coupled reactions. Vitamin K epoxide is then re-converted into vitamin K by the vitamin K epoxide reductase. These two enzymes comprise the so-called vitamin K cycle. One of the reasons why vitamin K is rarely deficient in a human diet is because vitamin K is continually recycled in our cells. Vitamin K 2,3-epoxide is the substrate for vitamin K 2,3-epoxide reductase (VKOR) complex. Significantly increased level of serum vitamin K epoxide has been found in patients with familial multiple coagulation factor deficiency (PMID: 12384421). Accumulation of vitamin K1-2,3-epoxide in plasma is also a sensitive marker of the coumarin-like activity of drugs (PMID: 2401753). Vitamin K1 2,3-epoxide is a vitamin K derivative. Vitamin K needed for the posttranslational modification of certain proteins, mostly required for blood coagulation. Within the cell, Vitamin K undergoes electron reduction to a reduced form of Vitamin K (called Vitamin K hydroquinone) by the enzyme Vitamin K epoxide reductase (or VKOR). Another enzyme then oxidizes Vitamin K hydroquinone to allow carboxylation of Glutamate to Gamma-cabroxygluatmate (Gla); this enzyme is called the gamma-glutamyl carboxylase or the Vitamin K-dependent carboxylase. The carboxylation reaction will only proceed if the carboxylase enzyme is able to oxidize Vitamin K hydroquinone to vitamin K epoxide at the same time; the carboxylation and epoxidation reactions are said to be coupled reactions. Vitamin K epoxide is then re-converted to Vitamin K by the Vitamin K epoxide reductase. These two enzymes comprise the so-called Vitamin K cycle. One of the reasons why Vitamin K is rarely deficient in a human diet is because Vitamin K is continually recycled in our cells. Vitamin K 2,3-epoxide is the substrate for vitamin K 2,3-epoxide reductase (VKOR) complex. Significantly increased level of serum vitamin K epoxide has been found in patients with familial multiple coagulation factor deficiency. (PMID 12384421) Accumulation of vitamin K1-2,3-epoxide in plasma is also a sensitive marker of coumarin-like activity of drugs. (PMID 2401753) [HMDB]

   

ST 28:0;O5

campestan-2alpha,3alpha,6alpha,22R,23R-pentol

C28H50O5 (466.3658)


A brassinosteroid that is castasterone in which the oxo group at position 6 has been converted to a hydroxy group (the 6alpha-stereoisomer).

   

omega-Hydroxyphylloquinone

2-[(E)-16-hydroxy-3,7,11,15-tetramethylhexadec-2-enyl]-3-methylnaphthalene-1,4-dione

C31H46O3 (466.3447)


   

LysoSM(d18:0)

(2-{[(2S,3R)-2-amino-3-hydroxyoctadecyl phosphonato]oxy}ethyl)trimethylazanium

C23H51N2O5P (466.3535)


Sphingomyelin (d18:0/0:0) or LysoSM(d18:0) is a type of sphingolipid found in animal cell membranes, especially in the membranous myelin sheath which surrounds some nerve cell axons. It usually consists of phosphorylcholine and ceramide. In humans, sphingomyelin is the only membrane phospholipid not derived from glycerol. Like all sphingolipids, SPH has a ceramide core (sphingosine bonded to a fatty acid via an amide linkage). In addition it contains one polar head group, which is either phosphocholine or phosphoethanolamine. The plasma membrane of cells is highly enriched in sphingomyelin and is considered largely to be found in the exoplasmic leaflet of the cell membrane. However, there is some evidence that there may also be a sphingomyelin pool in the inner leaflet of the membrane. Moreover, neutral sphingomyelinase-2 - an enzyme that breaks down sphingomyelin into ceramide has been found to localise exclusively to the inner leaflet further suggesting that there may be sphingomyelin present there. Sphingomyelin can accumulate in a rare hereditary disease called Niemann-Pick Disease, types A and B. Niemann-Pick disease is a genetically-inherited disease caused by a deficiency in the enzyme Sphingomyelinase, which causes the accumulation of Sphingomyelin in spleen, liver, lungs, bone marrow, and the brain, causing irreversible neurological damage. SMs play a role in signal transduction. Sphingomyelins are synthesized by the transfer of phosphorylcholine from phosphatidylcholine to a ceramide in a reaction catalyzed by sphingomyelin synthase. Sphingomyelin (d18:0/0:0) or LysoSM(d18:0)is a type of sphingolipid found in animal cell membranes, especially in the membranous myelin sheath which surrounds some nerve cell axons. It usually consists of phosphorylcholine and ceramide. In humans, sphingomyelin is the only membrane phospholipid not derived from glycerol. Like all sphingolipids, SPH has a ceramide core (sphingosine bonded to a fatty acid via an amide linkage). In addition it contains one polar head group, which is either phosphocholine or phosphoethanolamine. The plasma membrane of cells is highly enriched in sphingomyelin and is considered largely to be found in the exoplasmic leaflet of the cell membrane. However, there is some evidence that there may also be a sphingomyelin pool in the inner leaflet of the membrane. Moreover, neutral sphingomyelinase-2 - an enzyme that breaks down sphingomyelin into ceramide has been found to localise exclusively to the inner leaflet further suggesting that there may be sphingomyelin present there. Sphingomyelin can accumulate in a rare hereditary disease called Niemann-Pick Disease, types A and B. Niemann-Pick disease is a genetically-inherited disease caused by a deficiency in the enzyme Sphingomyelinase, which causes the accumulation of Sphingomyelin in spleen, liver, lungs, bone marrow, and the brain, causing irreversible neurological damage. SMs play a role in signal transduction.

   

2,3-Epoxyphylloquinone

Naphth[2,3-b]oxirene-2,7-dione, 1a,7a-dihydro-1a-methyl-7a-(3,7,11,15-tetramethyl-2-hexadecenyl)-phylloquinone oxide

C31H46O3 (466.3447)


Vitamin K1 2,3-epoxide is a vitamin K derivative. Vitamin K needed for the posttranslational modification of certain proteins, mostly required for blood coagulation. Within the cell, Vitamin K undergoes electron reduction to a reduced form of Vitamin K (called Vitamin K hydroquinone) by the enzyme Vitamin K epoxide reductase (or VKOR). Another enzyme then oxidizes Vitamin K hydroquinone to allow carboxylation of Glutamate to Gamma-cabroxygluatmate (Gla); this enzyme is called the gamma-glutamyl carboxylase or the Vitamin K-dependent carboxylase. The carboxylation reaction will only proceed if the carboxylase enzyme is able to oxidize Vitamin K hydroquinone to vitamin K epoxide at the same time; the carboxylation and epoxidation reactions are said to be coupled reactions. Vitamin K epoxide is then re-converted to Vitamin K by the Vitamin K epoxide reductase. These two enzymes comprise the so-called Vitamin K cycle. One of the reasons why Vitamin K is rarely deficient in a human diet is because Vitamin K is continually recycled in our cells. Vitamin K 2,3-epoxide is the substrate for vitamin K 2,3-epoxide reductase (VKOR) complex. Significantly increased level of serum vitamin K epoxide has been found in patients with familial multiple coagulation factor deficiency. (PMID 12384421) Accumulation of vitamin K1-2,3-epoxide in plasma is also a sensitive marker of coumarin-like activity of drugs. (PMID 2401753) [HMDB]

   

6alpha-hydroxy-castasterone

14-(3,4-dihydroxy-5,6-dimethylheptan-2-yl)-2,15-dimethyltetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadecane-4,5,8-triol

C28H50O5 (466.3658)


6alpha-hydroxy-castasterone belongs to pentahydroxy bile acids, alcohols and derivatives class of compounds. Those are bile acids, alcohols or derivatives bearing five hydroxyl groups. 6alpha-hydroxy-castasterone is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). 6alpha-hydroxy-castasterone can be found in a number of food items such as common salsify, chicory roots, muscadine grape, and ginseng, which makes 6alpha-hydroxy-castasterone a potential biomarker for the consumption of these food products.

   

Epipachysandrine A

Epipachysandrine A

C30H46N2O2 (466.3559)


   

Certonardosterol D5

Certonardosterol D5

C28H50O5 (466.3658)


   

Corticatic acid E

(-)-Corticatic acid E

C31H46O3 (466.3447)


   

Haliclonacyclamine F

Haliclonacyclamine F

C32H54N2 (466.4287)


   

Enervosanone

Enervosanone

C31H46O3 (466.3447)


   

Tillandsinone

Tillandsinone

C33H54O (466.4174)


   

haliclonacyclamine E

haliclonacyclamine E

C32H54N2 (466.4287)


   

24,24,27-Trimethylcycloart-25-en-3-one

24,24,27-Trimethylcycloart-25-en-3-one

C33H54O (466.4174)


   

SPBio_001937

SPBio_001937

C32H50O2 (466.3811)


   

gigantursenyl acetate A|urs-18beta-H-12,20(30)-dien-3beta-yl acetate

gigantursenyl acetate A|urs-18beta-H-12,20(30)-dien-3beta-yl acetate

C32H50O2 (466.3811)


   

calotroplupenyl acetate A|lup-13(18),19(29)-dien-9alpha-yl acetate

calotroplupenyl acetate A|lup-13(18),19(29)-dien-9alpha-yl acetate

C32H50O2 (466.3811)


   
   

Ursa-9(11),12-dien-3-yl acetate #

Ursa-9(11),12-dien-3-yl acetate #

C32H50O2 (466.3811)


   

24-Methylen-3-oxo-lanosta-7,9(11)-dien-21-saeure|3-oxo-eburica-7,9(11),24(28)-trien-21-oic acid|3-Oxo-eburica-7,9(11),24(28)-trien-21-saeure|7.11-Didehydro-eburiconsaeure|dehydroeburicoic acid|dehydroeburiconic acid

24-Methylen-3-oxo-lanosta-7,9(11)-dien-21-saeure|3-oxo-eburica-7,9(11),24(28)-trien-21-oic acid|3-Oxo-eburica-7,9(11),24(28)-trien-21-saeure|7.11-Didehydro-eburiconsaeure|dehydroeburicoic acid|dehydroeburiconic acid

C31H46O3 (466.3447)


   

4alpha-methyl-5alpha-stigmasta-8,14,Z-24(28)-trien-3beta-yl acetate|4alpha-Methylvernosterol acetate

4alpha-methyl-5alpha-stigmasta-8,14,Z-24(28)-trien-3beta-yl acetate|4alpha-Methylvernosterol acetate

C32H50O2 (466.3811)


   

ferna-7:9(11)-dien-3beta-yl acetate

ferna-7:9(11)-dien-3beta-yl acetate

C32H50O2 (466.3811)


   

3beta-acetoxy-swerta-7,9(11)-diene|3beta-acetoxyswerta-7,9(11)-diene

3beta-acetoxy-swerta-7,9(11)-diene|3beta-acetoxyswerta-7,9(11)-diene

C32H50O2 (466.3811)


   

Toxistylide B

Toxistylide B

C31H46O3 (466.3447)


   

calotropursenyl acetate|urs-12,19(29)-dien-3beta-yl acetate

calotropursenyl acetate|urs-12,19(29)-dien-3beta-yl acetate

C32H50O2 (466.3811)


   

3beta-Acetoxylupa-12,20(30)-dien|Dehydrolupeol-acetat|Delta-12,13 lupeol acetate

3beta-Acetoxylupa-12,20(30)-dien|Dehydrolupeol-acetat|Delta-12,13 lupeol acetate

C32H50O2 (466.3811)


   

Maragenin-II-acetat

Maragenin-II-acetat

C31H46O3 (466.3447)


   

(24S)-24-methylcholestane-1beta,3beta,5alpha,6beta,25-pentol

(24S)-24-methylcholestane-1beta,3beta,5alpha,6beta,25-pentol

C28H50O5 (466.3658)


   

(E)-N-[(20S)-20-(dimethylamino)-2beta-hydroxy-5alpha-pregnane-3beta-yl]benzamide|2beta-hydroxyepipachysamine D|2beta-hydroxyepipachysamine-D

(E)-N-[(20S)-20-(dimethylamino)-2beta-hydroxy-5alpha-pregnane-3beta-yl]benzamide|2beta-hydroxyepipachysamine D|2beta-hydroxyepipachysamine-D

C30H46N2O2 (466.3559)


   

ursa-13(18),19(29)-dien-3alpha-yl acetate

ursa-13(18),19(29)-dien-3alpha-yl acetate

C32H50O2 (466.3811)


   

5-Monohydroxy-phyllochinon (5-HOK)

5-Monohydroxy-phyllochinon (5-HOK)

C31H46O3 (466.3447)


   

(-)-duryne C

(-)-duryne C

C32H50O2 (466.3811)


An enyne that is (4E,11Z,17Z,28E)-dotriaconta-4,11,17,28-tetraene-1,31-diyne substituted by hydroxy groups at positions 3 and 30 (the 3R,30R-stereoisomer). It has been isolated from the marine sponge Petrosia.

   

peruvianursenyl acetate B|ursa-5,12-dien-18alphaH-3beta-yl acetate

peruvianursenyl acetate B|ursa-5,12-dien-18alphaH-3beta-yl acetate

C32H50O2 (466.3811)


   

(24S)-ergostane-3beta,5alpha,6beta,11alpha-tetraol

(24S)-ergostane-3beta,5alpha,6beta,11alpha-tetraol

C28H50O5 (466.3658)


   

balansinone|rel-(8S,9S,11R,13R,14S,17R,20S,22R,24S)-22-hydroxy-9,11-epoxy-24-methyl-9(10?19)abeo-lanost-25(10),25-trien-1-one

balansinone|rel-(8S,9S,11R,13R,14S,17R,20S,22R,24S)-22-hydroxy-9,11-epoxy-24-methyl-9(10?19)abeo-lanost-25(10),25-trien-1-one

C31H46O3 (466.3447)


   

lokysterolamine A

lokysterolamine A

C31H50N2O (466.3923)


   

(24S)-ergostane-3beta,5alpha,6beta,7beta,15beta-pentol

(24S)-ergostane-3beta,5alpha,6beta,7beta,15beta-pentol

C28H50O5 (466.3658)


   

(24S)-24-methyl-5alpha-cholestane-3beta,5,6beta,25xi,26-pentol|(24S)-24-methylcholestane-3beta,5alpha,6beta,25xi,26-pentol

(24S)-24-methyl-5alpha-cholestane-3beta,5,6beta,25xi,26-pentol|(24S)-24-methylcholestane-3beta,5alpha,6beta,25xi,26-pentol

C28H50O5 (466.3658)


   

lupa-5,20(29)-dien-3beta-yl acetate|lupedienyl acetate

lupa-5,20(29)-dien-3beta-yl acetate|lupedienyl acetate

C32H50O2 (466.3811)


   

anhydrosophoradiol-3-acetate

anhydrosophoradiol-3-acetate

C32H50O2 (466.3811)


   
   

SCHEMBL16227268

SCHEMBL16227268

C28H50O5 (466.3658)


   
   

(4aR)-10c-Acetoxy-2.2.4ar.6at.6bc.9.9.12ac-octamethyl-(8atH.12btH)-Delta13.14a-octadecahydro-picen|3-Ac-3beta-11,13(18)-Oleanadien-3-ol|3beta-Acetoxy-oleana-11,13(18)-dien|3beta-acetoxy-oleana-11,13(18)-diene|3beta-Acetoxyolean-11,13(18)-diene|3beta-acetoxyolean-11,13-diene|Olean-11,13(18)-diene-3??-yl acetate|oleana-11,13(18)-dien-3beta-yl acetate|Oleana-11,13(18)-dienyl-3beta-acetat|oleana-11:13(18)-dien-3beta-yl acetate

(4aR)-10c-Acetoxy-2.2.4ar.6at.6bc.9.9.12ac-octamethyl-(8atH.12btH)-Delta13.14a-octadecahydro-picen|3-Ac-3beta-11,13(18)-Oleanadien-3-ol|3beta-Acetoxy-oleana-11,13(18)-dien|3beta-acetoxy-oleana-11,13(18)-diene|3beta-Acetoxyolean-11,13(18)-diene|3beta-acetoxyolean-11,13-diene|Olean-11,13(18)-diene-3??-yl acetate|oleana-11,13(18)-dien-3beta-yl acetate|Oleana-11,13(18)-dienyl-3beta-acetat|oleana-11:13(18)-dien-3beta-yl acetate

C32H50O2 (466.3811)


   

(all-E)-6,10,14,18,22,26-hexamethyl-heptacosa-5,9,13,17,21,25-hexaen-2-one|2,6,10,14,18,22-Hexamethyl-26-oxo-heptacosahexaen-(2.6.10.14.18.22)|6,10,14,18,22,26-Hexamethyl-heptacosa-5t,9t,13t,17t21t,25-hexaen-2-on|6,10,14,18,22,26-hexamethyl-heptacosa-5t,9t,13t,17t21t,25-hexaen-2-one|all-trans-Farnesylfarnesylaceton

(all-E)-6,10,14,18,22,26-hexamethyl-heptacosa-5,9,13,17,21,25-hexaen-2-one|2,6,10,14,18,22-Hexamethyl-26-oxo-heptacosahexaen-(2.6.10.14.18.22)|6,10,14,18,22,26-Hexamethyl-heptacosa-5t,9t,13t,17t21t,25-hexaen-2-on|6,10,14,18,22,26-hexamethyl-heptacosa-5t,9t,13t,17t21t,25-hexaen-2-one|all-trans-Farnesylfarnesylaceton

C33H54O (466.4174)


   

3-Ac-3beta-9(11),12-Oleanadien-3-ol|3-acetoxyolean-9,12-dien|3beta-acetoxy-olean-9(11),12-diene|3beta-acetoxy-olean-9,12-diene|3beta-Acetoxyolean-9(11),12-diene|acetic acid oleana-9(11),12-dien-3beta-yl ester|olean-9(11),12(13)-dien-3beta-yl acetate|oleana-9(11),12-dien-3-yl acetate|oleana-9(11):12-dien-3beta-yl acetate

3-Ac-3beta-9(11),12-Oleanadien-3-ol|3-acetoxyolean-9,12-dien|3beta-acetoxy-olean-9(11),12-diene|3beta-acetoxy-olean-9,12-diene|3beta-Acetoxyolean-9(11),12-diene|acetic acid oleana-9(11),12-dien-3beta-yl ester|olean-9(11),12(13)-dien-3beta-yl acetate|oleana-9(11),12-dien-3-yl acetate|oleana-9(11):12-dien-3beta-yl acetate

C32H50O2 (466.3811)


   
   

Ergosterol Acetate

Ergosterol Acetate

C32H50O2 (466.3811)


   

Valactamide C putative

Valactamide C putative

C27H50N2O4 (466.377)


   

4-Apo-3,4-didehydrolycopene/ (4-Apo-3,4-didehydrolycopene)

4-Apo-3,4-didehydrolycopene/ (4-Apo-3,4-didehydrolycopene)

C35H46 (466.3599)


   

SM(d18:0/0:0)

Sphinganine-1-phosphocholine

C23H51N2O5P (466.3535)


   

6α-Hydroxycastasterone

campestan-2alpha,3alpha,6alpha,22R,23R-pentol

C28H50O5 (466.3658)


   

(5Z,7E,17Z)-(1S,3R)-26,27-dimethyl-24a,24b-dihomo-9,10-seco-5,7,10(19),17(20)-cholestatetraen-22-yne-1,3,25-triol

(17Z)-1α,25-dihydroxy-26,27-dimethyl-17,20,22,22,23,23-hexadehydro-24a,24b-dihomovitamin D3 / (17Z)-1α,25-dihydroxy-26,27-dimethyl-17,20,22,22,23,23-hexadehydro-24a,24b-dihomocholecalciferol

C31H46O3 (466.3447)


   

Commikuanoid A

21alpha-methoxy-21,23alpha-epoxy-cycloart-1,24-diene-3-one

C31H46O3 (466.3447)


   

Commikuanoid C

21beta-methoxy-21,23beta-epoxy-cycloart-1,24-diene-3-one

C31H46O3 (466.3447)


   

(17Z)-1alpha,25-dihydroxy-26,27-dimethyl-17,20,22,22,23,23-hexadehydro-24a,24b-dihomovitamin D3

(5Z,7E,17Z)-(1S,3R)-26,27-dimethyl-24a,24b-dihomo-9,10-seco-5,7,10(19),17(20)-cholestatetraen-22-yne-1,3,25-triol

C31H46O3 (466.3447)


   

4-Apo-3,4-didehydrolycopene

3,4-Didehydro-4-apo-psi,psi-carotene

C35H46 (466.3599)


   

2,3-epoxyphylloquinone

7a-methyl-1a-[(2E,7R,11R)-3,7,11,15-tetramethylhexadec-2-en-1-yl]-1a,7a-dihydronaphtho[2,3-b]oxirene-2,7-dione

C31H46O3 (466.3447)


   

HEPTAETHYLENE GLYCOL MONODECYL ETHER

HEPTAETHYLENE GLYCOL MONODECYL ETHER

C24H50O8 (466.3506)


   

N-[3-(dimethylamino)propyl]stearamide phosphate

N-[3-(dimethylamino)propyl]stearamide phosphate

C23H51N2O5P (466.3535)


   

3,7,11,18,22,26-hexaazatricyclo-{26.2.2.2(13,16)}tetratriaconta-1(31),13(33),14,16(34),28(32),29-hexaene

3,7,11,18,22,26-hexaazatricyclo-{26.2.2.2(13,16)}tetratriaconta-1(31),13(33),14,16(34),28(32),29-hexaene

C28H46N6 (466.3784)


   

9 9-DIOCTYL-2 7-DI-1-PROPYNYL-9H-FLUORE&

9 9-DIOCTYL-2 7-DI-1-PROPYNYL-9H-FLUORE&

C35H46 (466.3599)


   

(2-FLUOROPHENYL)THIO]ACETICACID

(2-FLUOROPHENYL)THIO]ACETICACID

C31H46O3 (466.3447)


   

(TRANS,TRANS)-4-PROPYL[1,1-BICYCLOHEXYL]-4-CARBOXYLIC ACID-4- (TRANS-4-BUTYLCYCLOHEXYL)PHENYL ESTER

(TRANS,TRANS)-4-PROPYL[1,1-BICYCLOHEXYL]-4-CARBOXYLIC ACID-4- (TRANS-4-BUTYLCYCLOHEXYL)PHENYL ESTER

C32H50O2 (466.3811)


   

6,10,14,18,22,26-Hexamethyl-heptacos-5,9,13,17,21,25-hexaen-2-one

6,10,14,18,22,26-Hexamethyl-heptacos-5,9,13,17,21,25-hexaen-2-one

C33H54O (466.4174)


   

6alpha-hydroxy-castasterone

14-(3,4-dihydroxy-5,6-dimethylheptan-2-yl)-2,15-dimethyltetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadecane-4,5,8-triol

C28H50O5 (466.3658)


6alpha-hydroxy-castasterone belongs to pentahydroxy bile acids, alcohols and derivatives class of compounds. Those are bile acids, alcohols or derivatives bearing five hydroxyl groups. 6alpha-hydroxy-castasterone is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). 6alpha-hydroxy-castasterone can be found in a number of food items such as common salsify, chicory roots, muscadine grape, and ginseng, which makes 6alpha-hydroxy-castasterone a potential biomarker for the consumption of these food products. 6α-hydroxy-castasterone belongs to pentahydroxy bile acids, alcohols and derivatives class of compounds. Those are bile acids, alcohols or derivatives bearing five hydroxyl groups. 6α-hydroxy-castasterone is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). 6α-hydroxy-castasterone can be found in a number of food items such as common salsify, chicory roots, muscadine grape, and ginseng, which makes 6α-hydroxy-castasterone a potential biomarker for the consumption of these food products.

   

Phytonadione epoxide, (E,2S,3R)-

Phytonadione epoxide, (E,2S,3R)-

C31H46O3 (466.3447)


   

[3-carboxy-2-[(8E,11E,13E)-15-hydroxyicosa-8,11,13-trienoyl]oxypropyl]-trimethylazanium

[3-carboxy-2-[(8E,11E,13E)-15-hydroxyicosa-8,11,13-trienoyl]oxypropyl]-trimethylazanium

C27H48NO5+ (466.3532)


   

[3-carboxy-2-[(9E,11E,14E)-8-hydroxyicosa-9,11,14-trienoyl]oxypropyl]-trimethylazanium

[3-carboxy-2-[(9E,11E,14E)-8-hydroxyicosa-9,11,14-trienoyl]oxypropyl]-trimethylazanium

C27H48NO5+ (466.3532)


   

[3-carboxy-2-[(5E,8E,11E)-3-hydroxyicosa-5,8,11-trienoyl]oxypropyl]-trimethylazanium

[3-carboxy-2-[(5E,8E,11E)-3-hydroxyicosa-5,8,11-trienoyl]oxypropyl]-trimethylazanium

C27H48NO5+ (466.3532)


   

[3-carboxy-2-[(8E,11E,14E)-3-hydroxyicosa-8,11,14-trienoyl]oxypropyl]-trimethylazanium

[3-carboxy-2-[(8E,11E,14E)-3-hydroxyicosa-8,11,14-trienoyl]oxypropyl]-trimethylazanium

C27H48NO5+ (466.3532)


   

[3-carboxy-2-[(8E,11E)-henicosa-8,11-dienoyl]oxypropyl]-trimethylazanium

[3-carboxy-2-[(8E,11E)-henicosa-8,11-dienoyl]oxypropyl]-trimethylazanium

C28H52NO4+ (466.3896)


   

[3-carboxy-2-[(11E,14E)-henicosa-11,14-dienoyl]oxypropyl]-trimethylazanium

[3-carboxy-2-[(11E,14E)-henicosa-11,14-dienoyl]oxypropyl]-trimethylazanium

C28H52NO4+ (466.3896)


   

[3-Carboxy-2-[9-(3,4-dimethyl-5-pentylfuran-2-yl)nonanoyloxy]propyl]-trimethylazanium

[3-Carboxy-2-[9-(3,4-dimethyl-5-pentylfuran-2-yl)nonanoyloxy]propyl]-trimethylazanium

C27H48NO5+ (466.3532)


   

[3-Carboxy-2-[11-(3,4-dimethyl-5-propylfuran-2-yl)undecanoyloxy]propyl]-trimethylazanium

[3-Carboxy-2-[11-(3,4-dimethyl-5-propylfuran-2-yl)undecanoyloxy]propyl]-trimethylazanium

C27H48NO5+ (466.3532)


   

[3-Carboxy-2-[7-(5-heptyl-3,4-dimethylfuran-2-yl)heptanoyloxy]propyl]-trimethylazanium

[3-Carboxy-2-[7-(5-heptyl-3,4-dimethylfuran-2-yl)heptanoyloxy]propyl]-trimethylazanium

C27H48NO5+ (466.3532)


   

[3-Carboxy-2-[9-(5-hexyl-3-methylfuran-2-yl)nonanoyloxy]propyl]-trimethylazanium

[3-Carboxy-2-[9-(5-hexyl-3-methylfuran-2-yl)nonanoyloxy]propyl]-trimethylazanium

C27H48NO5+ (466.3532)


   

6alpha-hydroxy-castasterone

6alpha-hydroxy-castasterone

C28H50O5 (466.3658)


   

[17-[(E)-5,6-dimethylhept-3-en-2-yl]-4,4,10,13-tetramethyl-1,2,3,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-3-yl] acetate

[17-[(E)-5,6-dimethylhept-3-en-2-yl]-4,4,10,13-tetramethyl-1,2,3,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-3-yl] acetate

C32H50O2 (466.3811)


   

(1-hydroxy-3-octoxypropan-2-yl) (9Z,12Z)-octadeca-9,12-dienoate

(1-hydroxy-3-octoxypropan-2-yl) (9Z,12Z)-octadeca-9,12-dienoate

C29H54O4 (466.4022)


   

[1-hydroxy-3-[(11Z,14Z)-icosa-11,14-dienoxy]propan-2-yl] hexanoate

[1-hydroxy-3-[(11Z,14Z)-icosa-11,14-dienoxy]propan-2-yl] hexanoate

C29H54O4 (466.4022)


   

(1-hydroxy-3-nonoxypropan-2-yl) (9Z,12Z)-heptadeca-9,12-dienoate

(1-hydroxy-3-nonoxypropan-2-yl) (9Z,12Z)-heptadeca-9,12-dienoate

C29H54O4 (466.4022)


   

[1-hydroxy-3-[(13Z,16Z)-tetracosa-13,16-dienoxy]propan-2-yl] acetate

[1-hydroxy-3-[(13Z,16Z)-tetracosa-13,16-dienoxy]propan-2-yl] acetate

C29H54O4 (466.4022)


   

[1-hydroxy-3-[(9Z,12Z)-nonadeca-9,12-dienoxy]propan-2-yl] heptanoate

[1-hydroxy-3-[(9Z,12Z)-nonadeca-9,12-dienoxy]propan-2-yl] heptanoate

C29H54O4 (466.4022)


   

[1-hydroxy-3-[(9Z,12Z)-octadeca-9,12-dienoxy]propan-2-yl] octanoate

[1-hydroxy-3-[(9Z,12Z)-octadeca-9,12-dienoxy]propan-2-yl] octanoate

C29H54O4 (466.4022)


   

[1-[(9Z,12Z)-heptadeca-9,12-dienoxy]-3-hydroxypropan-2-yl] nonanoate

[1-[(9Z,12Z)-heptadeca-9,12-dienoxy]-3-hydroxypropan-2-yl] nonanoate

C29H54O4 (466.4022)


   

[1-[(13Z,16Z)-docosa-13,16-dienoxy]-3-hydroxypropan-2-yl] butanoate

[1-[(13Z,16Z)-docosa-13,16-dienoxy]-3-hydroxypropan-2-yl] butanoate

C29H54O4 (466.4022)


   

[1-[(11Z,14Z)-henicosa-11,14-dienoxy]-3-hydroxypropan-2-yl] pentanoate

[1-[(11Z,14Z)-henicosa-11,14-dienoxy]-3-hydroxypropan-2-yl] pentanoate

C29H54O4 (466.4022)


   

[1-hydroxy-3-[(Z)-tridec-9-enoxy]propan-2-yl] (Z)-tridec-9-enoate

[1-hydroxy-3-[(Z)-tridec-9-enoxy]propan-2-yl] (Z)-tridec-9-enoate

C29H54O4 (466.4022)


   

[1-[(9Z,12Z)-hexadeca-9,12-dienoxy]-3-hydroxypropan-2-yl] decanoate

[1-[(9Z,12Z)-hexadeca-9,12-dienoxy]-3-hydroxypropan-2-yl] decanoate

C29H54O4 (466.4022)


   

(1-decoxy-3-hydroxypropan-2-yl) (9Z,12Z)-hexadeca-9,12-dienoate

(1-decoxy-3-hydroxypropan-2-yl) (9Z,12Z)-hexadeca-9,12-dienoate

C29H54O4 (466.4022)


   
   

[3-carboxy-2-[(9E,11E)-henicosa-9,11-dienoyl]oxypropyl]-trimethylazanium

[3-carboxy-2-[(9E,11E)-henicosa-9,11-dienoyl]oxypropyl]-trimethylazanium

C28H52NO4+ (466.3896)


   

2,3-dihydroxypropyl (15Z,18Z)-hexacosa-15,18-dienoate

2,3-dihydroxypropyl (15Z,18Z)-hexacosa-15,18-dienoate

C29H54O4 (466.4022)


   

Fahfa 9:0/20:1

Fahfa 9:0/20:1

C29H54O4 (466.4022)


   

Fahfa 22:1/7:0

Fahfa 22:1/7:0

C29H54O4 (466.4022)


   

Fahfa 7:0/22:1

Fahfa 7:0/22:1

C29H54O4 (466.4022)


   

Fahfa 8:0/21:1

Fahfa 8:0/21:1

C29H54O4 (466.4022)


   

Fahfa 21:1/8:0

Fahfa 21:1/8:0

C29H54O4 (466.4022)


   

Fahfa 3:0/26:1

Fahfa 3:0/26:1

C29H54O4 (466.4022)


   

Fahfa 20:1/9:0

Fahfa 20:1/9:0

C29H54O4 (466.4022)


   

Fahfa 24:1/5:0

Fahfa 24:1/5:0

C29H54O4 (466.4022)


   

Fahfa 26:1/3:0

Fahfa 26:1/3:0

C29H54O4 (466.4022)


   

Fahfa 5:0/24:1

Fahfa 5:0/24:1

C29H54O4 (466.4022)


   

Fahfa 18:1/11:0

Fahfa 18:1/11:0

C29H54O4 (466.4022)


   

Fahfa 12:0/17:1

Fahfa 12:0/17:1

C29H54O4 (466.4022)


   

Fahfa 13:1/16:0

Fahfa 13:1/16:0

C29H54O4 (466.4022)


   

Fahfa 19:1/10:0

Fahfa 19:1/10:0

C29H54O4 (466.4022)


   

Fahfa 14:0/15:1

Fahfa 14:0/15:1

C29H54O4 (466.4022)


   

Fahfa 10:0/19:1

Fahfa 10:0/19:1

C29H54O4 (466.4022)


   

Fahfa 17:1/12:0

Fahfa 17:1/12:0

C29H54O4 (466.4022)


   

Fahfa 16:1/13:0

Fahfa 16:1/13:0

C29H54O4 (466.4022)


   

Fahfa 15:0/14:1

Fahfa 15:0/14:1

C29H54O4 (466.4022)


   

Fahfa 16:0/13:1

Fahfa 16:0/13:1

C29H54O4 (466.4022)


   

Fahfa 15:1/14:0

Fahfa 15:1/14:0

C29H54O4 (466.4022)


   

Fahfa 13:0/16:1

Fahfa 13:0/16:1

C29H54O4 (466.4022)


   

(1-hydroxy-3-octanoyloxypropan-2-yl) (9Z,12Z)-heptadeca-9,12-dienoate

(1-hydroxy-3-octanoyloxypropan-2-yl) (9Z,12Z)-heptadeca-9,12-dienoate

C28H50O5 (466.3658)


   

(11Z,14Z,17Z,20Z,23Z,26Z,29Z)-dotriaconta-11,14,17,20,23,26,29-heptaenoic acid

(11Z,14Z,17Z,20Z,23Z,26Z,29Z)-dotriaconta-11,14,17,20,23,26,29-heptaenoic acid

C32H50O2 (466.3811)


   

(1-hydroxy-3-nonanoyloxypropan-2-yl) (9Z,12Z)-hexadeca-9,12-dienoate

(1-hydroxy-3-nonanoyloxypropan-2-yl) (9Z,12Z)-hexadeca-9,12-dienoate

C28H50O5 (466.3658)


   

(E)-8-undecanoyloxyoctadec-9-enoic acid

(E)-8-undecanoyloxyoctadec-9-enoic acid

C29H54O4 (466.4022)


   

(Z)-8-undecanoyloxyoctadec-9-enoic acid

(Z)-8-undecanoyloxyoctadec-9-enoic acid

C29H54O4 (466.4022)


   

(1-butanoyloxy-3-hydroxypropan-2-yl) (11Z,14Z)-henicosa-11,14-dienoate

(1-butanoyloxy-3-hydroxypropan-2-yl) (11Z,14Z)-henicosa-11,14-dienoate

C28H50O5 (466.3658)


   

(1-hydroxy-3-pentanoyloxypropan-2-yl) (11Z,14Z)-icosa-11,14-dienoate

(1-hydroxy-3-pentanoyloxypropan-2-yl) (11Z,14Z)-icosa-11,14-dienoate

C28H50O5 (466.3658)


   

(1-hexanoyloxy-3-hydroxypropan-2-yl) (9Z,12Z)-nonadeca-9,12-dienoate

(1-hexanoyloxy-3-hydroxypropan-2-yl) (9Z,12Z)-nonadeca-9,12-dienoate

C28H50O5 (466.3658)


   

(1-hydroxy-3-propanoyloxypropan-2-yl) (13Z,16Z)-docosa-13,16-dienoate

(1-hydroxy-3-propanoyloxypropan-2-yl) (13Z,16Z)-docosa-13,16-dienoate

C28H50O5 (466.3658)


   

(1-heptanoyloxy-3-hydroxypropan-2-yl) (9Z,12Z)-octadeca-9,12-dienoate

(1-heptanoyloxy-3-hydroxypropan-2-yl) (9Z,12Z)-octadeca-9,12-dienoate

C28H50O5 (466.3658)


   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

[(2S)-2,3-dihydroxypropyl] (5E,9E)-hexacosa-5,9-dienoate

[(2S)-2,3-dihydroxypropyl] (5E,9E)-hexacosa-5,9-dienoate

C29H54O4 (466.4022)


   

Sphinganine-1-phosphocholine

Sphinganine-1-phosphocholine

C23H51N2O5P (466.3535)


A phosphosphingolipid consisting of sphinganine having a phosphocholine group attached to its primary hydroxyl group.

   

Vitamin K epoxide

Vitamin K epoxide

C31H46O3 (466.3447)


   

DG(26:2)

DG(18:2(1)_8:0)

C29H54O4 (466.4022)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

Dotriacontaheptaenoic acid

Dotriacontaheptaenoic acid

C32H50O2 (466.3811)


   

NA-Gln 22:1(11Z)

NA-Gln 22:1(11Z)

C27H50N2O4 (466.377)


   

NA-Lys 22:1(11Z)

NA-Lys 22:1(11Z)

C28H54N2O3 (466.4134)


   
   

FAHFA 10:0/O-19:1

FAHFA 10:0/O-19:1

C29H54O4 (466.4022)


   

FAHFA 10:1/O-19:0

FAHFA 10:1/O-19:0

C29H54O4 (466.4022)


   

FAHFA 11:0/O-18:1

FAHFA 11:0/O-18:1

C29H54O4 (466.4022)


   

FAHFA 11:1(10E)/12O-18:0

FAHFA 11:1(10E)/12O-18:0

C29H54O4 (466.4022)


   

FAHFA 11:1/O-18:0

FAHFA 11:1/O-18:0

C29H54O4 (466.4022)


   

FAHFA 12:0/O-17:1

FAHFA 12:0/O-17:1

C29H54O4 (466.4022)


   

FAHFA 12:1/O-17:0

FAHFA 12:1/O-17:0

C29H54O4 (466.4022)


   

FAHFA 13:0/O-16:1

FAHFA 13:0/O-16:1

C29H54O4 (466.4022)


   

FAHFA 13:1(12E)/3O-16:0

FAHFA 13:1(12E)/3O-16:0

C29H54O4 (466.4022)


   

FAHFA 13:1/O-16:0

FAHFA 13:1/O-16:0

C29H54O4 (466.4022)


   

FAHFA 14:0/O-15:1

FAHFA 14:0/O-15:1

C29H54O4 (466.4022)


   

FAHFA 14:1(9Z)/15O-15:0

FAHFA 14:1(9Z)/15O-15:0

C29H54O4 (466.4022)


   

FAHFA 14:1/O-15:0

FAHFA 14:1/O-15:0

C29H54O4 (466.4022)


   

FAHFA 15:0/O-14:1

FAHFA 15:0/O-14:1

C29H54O4 (466.4022)


   

FAHFA 15:1(9Z)/2O-14:0

FAHFA 15:1(9Z)/2O-14:0

C29H54O4 (466.4022)


   

FAHFA 15:1/O-14:0

FAHFA 15:1/O-14:0

C29H54O4 (466.4022)


   

FAHFA 16:0/O-13:1

FAHFA 16:0/O-13:1

C29H54O4 (466.4022)


   

FAHFA 16:1(9Z)/3O-13:0

FAHFA 16:1(9Z)/3O-13:0

C29H54O4 (466.4022)


   

FAHFA 16:1/O-13:0

FAHFA 16:1/O-13:0

C29H54O4 (466.4022)


   

FAHFA 17:0/O-12:1

FAHFA 17:0/O-12:1

C29H54O4 (466.4022)


   

FAHFA 17:1(9Z)/3O-12:0

FAHFA 17:1(9Z)/3O-12:0

C29H54O4 (466.4022)


   

FAHFA 17:1/O-12:0

FAHFA 17:1/O-12:0

C29H54O4 (466.4022)


   

FAHFA 18:0/O-11:1

FAHFA 18:0/O-11:1

C29H54O4 (466.4022)


   

FAHFA 18:1(9Z)/3O-11:0

FAHFA 18:1(9Z)/3O-11:0

C29H54O4 (466.4022)


   

FAHFA 18:1/O-11:0

FAHFA 18:1/O-11:0

C29H54O4 (466.4022)


   

FAHFA 19:0/O-10:1

FAHFA 19:0/O-10:1

C29H54O4 (466.4022)


   

FAHFA 19:1(10Z)/3O-10:0

FAHFA 19:1(10Z)/3O-10:0

C29H54O4 (466.4022)


   

FAHFA 19:1/O-10:0

FAHFA 19:1/O-10:0

C29H54O4 (466.4022)


   

FAHFA 20:0/O-9:1

FAHFA 20:0/O-9:1

C29H54O4 (466.4022)


   

FAHFA 20:1(11Z)/3O-9:0

FAHFA 20:1(11Z)/3O-9:0

C29H54O4 (466.4022)


   

FAHFA 20:1/O-9:0

FAHFA 20:1/O-9:0

C29H54O4 (466.4022)


   

FAHFA 21:0/O-8:1

FAHFA 21:0/O-8:1

C29H54O4 (466.4022)


   

FAHFA 21:1/O-8:0

FAHFA 21:1/O-8:0

C29H54O4 (466.4022)


   

FAHFA 23:1(14Z)/3O-6:0

FAHFA 23:1(14Z)/3O-6:0

C29H54O4 (466.4022)


   

FAHFA 29:1;O

FAHFA 29:1;O

C29H54O4 (466.4022)


   

FAHFA 8:0/O-21:1

FAHFA 8:0/O-21:1

C29H54O4 (466.4022)


   

FAHFA 8:1/O-21:0

FAHFA 8:1/O-21:0

C29H54O4 (466.4022)


   

FAHFA 9:0/O-20:1

FAHFA 9:0/O-20:1

C29H54O4 (466.4022)


   

FAHFA 9:1/O-20:0

FAHFA 9:1/O-20:0

C29H54O4 (466.4022)


   

DG P-16:1_10:0

DG P-16:1_10:0

C29H54O4 (466.4022)


   
   
   

Epoxyphylloquinone

Epoxyphylloquinone

C31H46O3 (466.3447)


   

Hydroxycastasterone

Hydroxycastasterone

C28H50O5 (466.3658)


   

(1r,5as,6s,7s,9as,11ar)-1-[(2r,5z)-5-isopropylhept-5-en-2-yl]-6,9a,11a-trimethyl-1h,2h,4h,5h,5ah,6h,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-7-yl acetate

(1r,5as,6s,7s,9as,11ar)-1-[(2r,5z)-5-isopropylhept-5-en-2-yl]-6,9a,11a-trimethyl-1h,2h,4h,5h,5ah,6h,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-7-yl acetate

C32H50O2 (466.3811)


   

4,4,6a,6b,8a,11,11,14b-octamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a-dodecahydropicen-3-yl acetate

4,4,6a,6b,8a,11,11,14b-octamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a-dodecahydropicen-3-yl acetate

C32H50O2 (466.3811)


   

(1s,5r,7r)-1-[(2e)-3,7-dimethylocta-2,6-dien-1-yl]-6,6-dimethyl-5,7-bis(3-methylbut-2-en-1-yl)bicyclo[3.3.1]nonane-2,4,9-trione

(1s,5r,7r)-1-[(2e)-3,7-dimethylocta-2,6-dien-1-yl]-6,6-dimethyl-5,7-bis(3-methylbut-2-en-1-yl)bicyclo[3.3.1]nonane-2,4,9-trione

C31H46O3 (466.3447)


   

1-(6,7-dihydroxy-5,6-dimethylheptan-2-yl)-9a,11a-dimethyl-tetradecahydrocyclopenta[a]phenanthrene-5,5a,7-triol

1-(6,7-dihydroxy-5,6-dimethylheptan-2-yl)-9a,11a-dimethyl-tetradecahydrocyclopenta[a]phenanthrene-5,5a,7-triol

C28H50O5 (466.3658)


   

(1r,3r,3as,3br,5s,5as,7s,9ar,9bs,11ar)-1-[(2r,5s)-5,6-dihydroxy-5-isopropylhexan-2-yl]-9a,11a-dimethyl-tetradecahydro-1h-cyclopenta[a]phenanthrene-3,5,7-triol

(1r,3r,3as,3br,5s,5as,7s,9ar,9bs,11ar)-1-[(2r,5s)-5,6-dihydroxy-5-isopropylhexan-2-yl]-9a,11a-dimethyl-tetradecahydro-1h-cyclopenta[a]phenanthrene-3,5,7-triol

C28H50O5 (466.3658)


   

n-[(1s,3as,3br,5as,7r,8s,9as,9bs,11as)-1-[(1s)-1-(dimethylamino)ethyl]-8-hydroxy-9a,11a-dimethyl-tetradecahydro-1h-cyclopenta[a]phenanthren-7-yl]benzenecarboximidic acid

n-[(1s,3as,3br,5as,7r,8s,9as,9bs,11as)-1-[(1s)-1-(dimethylamino)ethyl]-8-hydroxy-9a,11a-dimethyl-tetradecahydro-1h-cyclopenta[a]phenanthren-7-yl]benzenecarboximidic acid

C30H46N2O2 (466.3559)


   

(2r)-2-[(1r,3ar,5ar,9as,11ar)-3a,6,6,9a,11a-pentamethyl-7-oxo-1h,2h,3h,5h,5ah,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-6-methyl-5-methylideneheptanoic acid

(2r)-2-[(1r,3ar,5ar,9as,11ar)-3a,6,6,9a,11a-pentamethyl-7-oxo-1h,2h,3h,5h,5ah,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-6-methyl-5-methylideneheptanoic acid

C31H46O3 (466.3447)


   

(4e,12r,14r,19z,22z,29r,30s)-1,16-diazatetracyclo[27.3.1.1¹²,¹⁶.0¹⁴,³⁰]tetratriaconta-4,19,22-triene

(4e,12r,14r,19z,22z,29r,30s)-1,16-diazatetracyclo[27.3.1.1¹²,¹⁶.0¹⁴,³⁰]tetratriaconta-4,19,22-triene

C32H54N2 (466.4287)


   

2-[(1r,3ar,5ar,9as,11ar)-3a,6,6,9a,11a-pentamethyl-7-oxo-1h,2h,3h,5h,5ah,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-6-methyl-5-methylideneheptanoic acid

2-[(1r,3ar,5ar,9as,11ar)-3a,6,6,9a,11a-pentamethyl-7-oxo-1h,2h,3h,5h,5ah,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-6-methyl-5-methylideneheptanoic acid

C31H46O3 (466.3447)


   

(4as,6ar,6bs,13bs,15ar,15bs)-4,4,6a,8a,13b,15b-hexamethyl-1h,2h,3h,4ah,5h,6h,6bh,7h,8h,13h,13ah,14h,15h,15ah-indeno[2,1-a]chrysene-9,10,12-triol

(4as,6ar,6bs,13bs,15ar,15bs)-4,4,6a,8a,13b,15b-hexamethyl-1h,2h,3h,4ah,5h,6h,6bh,7h,8h,13h,13ah,14h,15h,15ah-indeno[2,1-a]chrysene-9,10,12-triol

C31H46O3 (466.3447)


   

n-{1-[1-(dimethylamino)ethyl]-6-hydroxy-9a,11a-dimethyl-tetradecahydro-1h-cyclopenta[a]phenanthren-7-yl}benzenecarboximidic acid

n-{1-[1-(dimethylamino)ethyl]-6-hydroxy-9a,11a-dimethyl-tetradecahydro-1h-cyclopenta[a]phenanthren-7-yl}benzenecarboximidic acid

C30H46N2O2 (466.3559)


   

(1s,3r,8r,11s,12s,15r,16r)-15-[(2r,5s)-5-isopropyl-6-methylhept-6-en-2-yl]-7,7,12,16-tetramethylpentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-6-one

(1s,3r,8r,11s,12s,15r,16r)-15-[(2r,5s)-5-isopropyl-6-methylhept-6-en-2-yl]-7,7,12,16-tetramethylpentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-6-one

C33H54O (466.4174)


   

11,13(18)-oleanadien-3-ol; 3β-form,3-ac

NA

C32H50O2 (466.3811)


{"Ingredient_id": "HBIN000260","Ingredient_name": "11,13(18)-oleanadien-3-ol; 3\u03b2-form,3-ac","Alias": "NA","Ingredient_formula": "C32H50O2","Ingredient_Smile": "NA","Ingredient_weight": "0","OB_score": "NA","CAS_id": "2118-75-4","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "9415","PubChem_id": "NA","DrugBank_id": "NA"}

   

(1r,3ar,5ar,6r,7s,9ar,9br,11ar)-7-(dimethylamino)-9a,11a-dimethyl-1-[(2r)-1-[3-(propan-2-ylidene)-4,5-dihydropyrrol-2-yl]propan-2-yl]-1h,2h,3h,3ah,5h,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-6-ol

(1r,3ar,5ar,6r,7s,9ar,9br,11ar)-7-(dimethylamino)-9a,11a-dimethyl-1-[(2r)-1-[3-(propan-2-ylidene)-4,5-dihydropyrrol-2-yl]propan-2-yl]-1h,2h,3h,3ah,5h,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-6-ol

C31H50N2O (466.3923)


   

(3s,4ar,6ar,6bs,14ar,14br)-4,4,6a,6b,11,11,14b-heptamethyl-8-oxo-1,2,3,4a,5,6,7,9,10,12,14,14a-dodecahydropicen-3-yl acetate

(3s,4ar,6ar,6bs,14ar,14br)-4,4,6a,6b,11,11,14b-heptamethyl-8-oxo-1,2,3,4a,5,6,7,9,10,12,14,14a-dodecahydropicen-3-yl acetate

C31H46O3 (466.3447)


   

5-(2-{3a,6,6,9a,11a-pentamethyl-7-oxo-1h,2h,3h,4h,5h,5ah,8h,9h,10h,11h-cyclopenta[a]phenanthren-1-yl}propyl)-3,4-dimethyl-5h-furan-2-one

5-(2-{3a,6,6,9a,11a-pentamethyl-7-oxo-1h,2h,3h,4h,5h,5ah,8h,9h,10h,11h-cyclopenta[a]phenanthren-1-yl}propyl)-3,4-dimethyl-5h-furan-2-one

C31H46O3 (466.3447)


   

(3r,6ar,6bs,8ar,12s,12as,14br)-4,4,6a,6b,8a,12,14b-heptamethyl-11-methylidene-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl acetate

(3r,6ar,6bs,8ar,12s,12as,14br)-4,4,6a,6b,8a,12,14b-heptamethyl-11-methylidene-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl acetate

C32H50O2 (466.3811)


   

(1s,16z,24r,25s,32r)-12,28-diazapentacyclo[22.7.1.1⁸,¹².0¹⁰,²⁵.0²⁸,³²]tritriaconta-8,16-dien-31-one

(1s,16z,24r,25s,32r)-12,28-diazapentacyclo[22.7.1.1⁸,¹².0¹⁰,²⁵.0²⁸,³²]tritriaconta-8,16-dien-31-one

C31H50N2O (466.3923)


   

2-[(2e,5s,7r,11r)-5-hydroxy-3,7,11,15-tetramethylhexadec-2-en-1-yl]-3-methylnaphthalene-1,4-dione

2-[(2e,5s,7r,11r)-5-hydroxy-3,7,11,15-tetramethylhexadec-2-en-1-yl]-3-methylnaphthalene-1,4-dione

C31H46O3 (466.3447)


   

15-(5-isopropyl-6-methylhept-6-en-2-yl)-7,7,12,16-tetramethylpentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-6-one

15-(5-isopropyl-6-methylhept-6-en-2-yl)-7,7,12,16-tetramethylpentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-6-one

C33H54O (466.4174)


   

(3r,3ar,5as,7ar,9s,11as,13as,13br)-3-isopropyl-3a,5a,8,8,11a,13a-hexamethyl-1h,2h,3h,4h,5h,7h,7ah,9h,10h,11h,13h,13bh-cyclopenta[a]chrysen-9-yl acetate

(3r,3ar,5as,7ar,9s,11as,13as,13br)-3-isopropyl-3a,5a,8,8,11a,13a-hexamethyl-1h,2h,3h,4h,5h,7h,7ah,9h,10h,11h,13h,13bh-cyclopenta[a]chrysen-9-yl acetate

C32H50O2 (466.3811)


   

2-(5-hydroxy-3,7,11,15-tetramethylhexadec-2-en-1-yl)-3-methylnaphthalene-1,4-dione

2-(5-hydroxy-3,7,11,15-tetramethylhexadec-2-en-1-yl)-3-methylnaphthalene-1,4-dione

C31H46O3 (466.3447)


   

(4z,12s,14s,19z,21z,29r,30s)-1,16-diazatetracyclo[27.3.1.1¹²,¹⁶.0¹⁴,³⁰]tetratriaconta-4,19,21-triene

(4z,12s,14s,19z,21z,29r,30s)-1,16-diazatetracyclo[27.3.1.1¹²,¹⁶.0¹⁴,³⁰]tetratriaconta-4,19,21-triene

C32H54N2 (466.4287)


   

1,16-diazatetracyclo[27.3.1.1¹²,¹⁶.0¹⁴,³⁰]tetratriaconta-4,19,21-triene

1,16-diazatetracyclo[27.3.1.1¹²,¹⁶.0¹⁴,³⁰]tetratriaconta-4,19,21-triene

C32H54N2 (466.4287)


   

3a,5a,5b,8,8,11a-hexamethyl-1-(prop-1-en-2-yl)-1h,2h,3h,4h,5h,6h,7h,7ah,9h,10h,11h,11bh,12h,13bh-cyclopenta[a]chrysen-9-yl acetate

3a,5a,5b,8,8,11a-hexamethyl-1-(prop-1-en-2-yl)-1h,2h,3h,4h,5h,6h,7h,7ah,9h,10h,11h,11bh,12h,13bh-cyclopenta[a]chrysen-9-yl acetate

C32H50O2 (466.3811)


   

(4z,12r,14r,19z,22z,29r,30s)-1,16-diazatetracyclo[27.3.1.1¹²,¹⁶.0¹⁴,³⁰]tetratriaconta-4,19,22-triene

(4z,12r,14r,19z,22z,29r,30s)-1,16-diazatetracyclo[27.3.1.1¹²,¹⁶.0¹⁴,³⁰]tetratriaconta-4,19,22-triene

C32H54N2 (466.4287)


   

n-[(6r,7s,9ar,11as)-1-[1-(dimethylamino)ethyl]-6-hydroxy-9a,11a-dimethyl-tetradecahydro-1h-cyclopenta[a]phenanthren-7-yl]benzenecarboximidic acid

n-[(6r,7s,9ar,11as)-1-[1-(dimethylamino)ethyl]-6-hydroxy-9a,11a-dimethyl-tetradecahydro-1h-cyclopenta[a]phenanthren-7-yl]benzenecarboximidic acid

C30H46N2O2 (466.3559)


   

n-{1-[1-(dimethylamino)ethyl]-8-hydroxy-9a,11a-dimethyl-tetradecahydro-1h-cyclopenta[a]phenanthren-7-yl}benzenecarboximidic acid

n-{1-[1-(dimethylamino)ethyl]-8-hydroxy-9a,11a-dimethyl-tetradecahydro-1h-cyclopenta[a]phenanthren-7-yl}benzenecarboximidic acid

C30H46N2O2 (466.3559)


   

(27e,29r)-29-hydroxyhentriaconta-4,17,20,27-tetraen-2,30-diynoic acid

(27e,29r)-29-hydroxyhentriaconta-4,17,20,27-tetraen-2,30-diynoic acid

C31H46O3 (466.3447)


   

(1r,2r,3ar,3bs,4r,5ar,7s,9as,9br,11as)-1-[(2r,5s)-5,6-dimethylheptan-2-yl]-9a,11a-dimethyl-dodecahydro-2h-cyclopenta[a]phenanthrene-1,2,3b,4,7-pentol

(1r,2r,3ar,3bs,4r,5ar,7s,9as,9br,11as)-1-[(2r,5s)-5,6-dimethylheptan-2-yl]-9a,11a-dimethyl-dodecahydro-2h-cyclopenta[a]phenanthrene-1,2,3b,4,7-pentol

C28H50O5 (466.3658)


   

(3s,6ar,6bs,8as,12s,12as,14br)-4,4,6a,6b,8a,11,12,14b-octamethyl-2,3,4a,5,6,7,8,9,12,12a,14,14a-dodecahydro-1h-picen-3-yl acetate

(3s,6ar,6bs,8as,12s,12as,14br)-4,4,6a,6b,8a,11,12,14b-octamethyl-2,3,4a,5,6,7,8,9,12,12a,14,14a-dodecahydro-1h-picen-3-yl acetate

C32H50O2 (466.3811)


   

(1r,3ar,5as,5br,7ar,9s,11ar,11br,13bs)-3a,5a,5b,8,8,11a-hexamethyl-1-(prop-1-en-2-yl)-1h,2h,3h,4h,5h,6h,7h,7ah,9h,10h,11h,11bh,12h,13bh-cyclopenta[a]chrysen-9-yl acetate

(1r,3ar,5as,5br,7ar,9s,11ar,11br,13bs)-3a,5a,5b,8,8,11a-hexamethyl-1-(prop-1-en-2-yl)-1h,2h,3h,4h,5h,6h,7h,7ah,9h,10h,11h,11bh,12h,13bh-cyclopenta[a]chrysen-9-yl acetate

C32H50O2 (466.3811)


   

1,16-diazatetracyclo[27.3.1.1¹²,¹⁶.0¹⁴,³⁰]tetratriaconta-4,19,22-triene

1,16-diazatetracyclo[27.3.1.1¹²,¹⁶.0¹⁴,³⁰]tetratriaconta-4,19,22-triene

C32H54N2 (466.4287)


   

1-(6-hydroxy-5,6-dimethylheptan-2-yl)-9a,11a-dimethyl-tetradecahydrocyclopenta[a]phenanthrene-5,5a,7,9-tetrol

1-(6-hydroxy-5,6-dimethylheptan-2-yl)-9a,11a-dimethyl-tetradecahydrocyclopenta[a]phenanthrene-5,5a,7,9-tetrol

C28H50O5 (466.3658)


   

7,7,12,16-tetramethyl-15-(6-methylhepta-1,5-dien-2-yl)pentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-6-yl acetate

7,7,12,16-tetramethyl-15-(6-methylhepta-1,5-dien-2-yl)pentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-6-yl acetate

C32H50O2 (466.3811)


   

1,16-diazatetracyclo[27.3.1.1¹²,¹⁶.0¹⁴,³⁰]tetratriaconta-4,21,23-triene

1,16-diazatetracyclo[27.3.1.1¹²,¹⁶.0¹⁴,³⁰]tetratriaconta-4,21,23-triene

C32H54N2 (466.4287)


   

1-(5-isopropylhept-5-en-2-yl)-6,9a,11a-trimethyl-1h,2h,4h,5h,5ah,6h,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-7-yl acetate

1-(5-isopropylhept-5-en-2-yl)-6,9a,11a-trimethyl-1h,2h,4h,5h,5ah,6h,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-7-yl acetate

C32H50O2 (466.3811)


   

4,4,6a,6b,11,11,14b-heptamethyl-8-oxo-1,2,3,4a,5,6,7,9,10,12,14,14a-dodecahydropicen-3-yl acetate

4,4,6a,6b,11,11,14b-heptamethyl-8-oxo-1,2,3,4a,5,6,7,9,10,12,14,14a-dodecahydropicen-3-yl acetate

C31H46O3 (466.3447)


   

1-(5,6-dimethylheptan-2-yl)-9a,11a-dimethyl-dodecahydro-2h-cyclopenta[a]phenanthrene-1,2,3b,4,7-pentol

1-(5,6-dimethylheptan-2-yl)-9a,11a-dimethyl-dodecahydro-2h-cyclopenta[a]phenanthrene-1,2,3b,4,7-pentol

C28H50O5 (466.3658)


   

3-isopropyl-3a,5a,8,8,11a,13a-hexamethyl-1h,2h,3h,4h,5h,7h,7ah,9h,10h,11h,13h,13bh-cyclopenta[a]chrysen-9-yl acetate

3-isopropyl-3a,5a,8,8,11a,13a-hexamethyl-1h,2h,3h,4h,5h,7h,7ah,9h,10h,11h,13h,13bh-cyclopenta[a]chrysen-9-yl acetate

C32H50O2 (466.3811)


   

(3s,4ar,6as,6br,8ar,11r,12s,12ar,14bs)-4,4,6a,6b,8a,11,12,14b-octamethyl-2,3,4a,5,6,7,8,9,10,11,12,12a-dodecahydro-1h-picen-3-yl acetate

(3s,4ar,6as,6br,8ar,11r,12s,12ar,14bs)-4,4,6a,6b,8a,11,12,14b-octamethyl-2,3,4a,5,6,7,8,9,10,11,12,12a-dodecahydro-1h-picen-3-yl acetate

C32H50O2 (466.3811)


   

(5s)-5-[(2r)-2-[(1r,3ar,5ar,9as,11ar)-3a,6,6,9a,11a-pentamethyl-7-oxo-1h,2h,3h,4h,5h,5ah,8h,9h,10h,11h-cyclopenta[a]phenanthren-1-yl]propyl]-3,4-dimethyl-5h-furan-2-one

(5s)-5-[(2r)-2-[(1r,3ar,5ar,9as,11ar)-3a,6,6,9a,11a-pentamethyl-7-oxo-1h,2h,3h,4h,5h,5ah,8h,9h,10h,11h-cyclopenta[a]phenanthren-1-yl]propyl]-3,4-dimethyl-5h-furan-2-one

C31H46O3 (466.3447)


   

4,4,6a,6b,8a,11,12,14b-octamethyl-2,3,4a,5,6,7,8,9,10,11,12,12a-dodecahydro-1h-picen-3-yl acetate

4,4,6a,6b,8a,11,12,14b-octamethyl-2,3,4a,5,6,7,8,9,10,11,12,12a-dodecahydro-1h-picen-3-yl acetate

C32H50O2 (466.3811)


   

29-hydroxyhentriaconta-4,17,20,27-tetraen-2,30-diynoic acid

29-hydroxyhentriaconta-4,17,20,27-tetraen-2,30-diynoic acid

C31H46O3 (466.3447)


   

(3s,4ar,6as,6br,8ar,12ar,14bs)-4,4,6a,6b,8a,11,11,14b-octamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a-dodecahydropicen-3-yl acetate

(3s,4ar,6as,6br,8ar,12ar,14bs)-4,4,6a,6b,8a,11,11,14b-octamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a-dodecahydropicen-3-yl acetate

C32H50O2 (466.3811)


   

n-[(1s,3as,3bs,5ar,6r,7s,9ar,9bs,11as)-1-[(1s)-1-(dimethylamino)ethyl]-6-hydroxy-9a,11a-dimethyl-tetradecahydro-1h-cyclopenta[a]phenanthren-7-yl]benzenecarboximidic acid

n-[(1s,3as,3bs,5ar,6r,7s,9ar,9bs,11as)-1-[(1s)-1-(dimethylamino)ethyl]-6-hydroxy-9a,11a-dimethyl-tetradecahydro-1h-cyclopenta[a]phenanthren-7-yl]benzenecarboximidic acid

C30H46N2O2 (466.3559)


   

(3s,4ar,6ar,6bs,8ar,14ar,14bs)-4,4,6a,6b,8a,11,11,14b-octamethyl-1,2,3,4a,5,6,7,8,9,10,12,14a-dodecahydropicen-3-yl acetate

(3s,4ar,6ar,6bs,8ar,14ar,14bs)-4,4,6a,6b,8a,11,11,14b-octamethyl-1,2,3,4a,5,6,7,8,9,10,12,14a-dodecahydropicen-3-yl acetate

C32H50O2 (466.3811)


   

(16z)-12,28-diazapentacyclo[22.7.1.1⁸,¹².0¹⁰,²⁵.0²⁸,³²]tritriaconta-8,16-dien-31-one

(16z)-12,28-diazapentacyclo[22.7.1.1⁸,¹².0¹⁰,²⁵.0²⁸,³²]tritriaconta-8,16-dien-31-one

C31H50N2O (466.3923)


   

(1s,3r,6s,8r,11s,12s,15r,16r)-7,7,12,16-tetramethyl-15-(6-methylhepta-1,5-dien-2-yl)pentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-6-yl acetate

(1s,3r,6s,8r,11s,12s,15r,16r)-7,7,12,16-tetramethyl-15-(6-methylhepta-1,5-dien-2-yl)pentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-6-yl acetate

C32H50O2 (466.3811)


   

(3r,4e,28e,30r)-dotriaconta-4,11,17,28-tetraen-1,31-diyne-3,30-diol

(3r,4e,28e,30r)-dotriaconta-4,11,17,28-tetraen-1,31-diyne-3,30-diol

C32H50O2 (466.3811)


   

(4z,17z,20z,27e,29r)-29-hydroxyhentriaconta-4,17,20,27-tetraen-2,30-diynoic acid

(4z,17z,20z,27e,29r)-29-hydroxyhentriaconta-4,17,20,27-tetraen-2,30-diynoic acid

C31H46O3 (466.3447)


   

4,4,6a,6b,8a,11,11,14b-octamethyl-1,2,3,4a,5,6,7,8,9,10,12,14a-dodecahydropicen-3-yl acetate

4,4,6a,6b,8a,11,11,14b-octamethyl-1,2,3,4a,5,6,7,8,9,10,12,14a-dodecahydropicen-3-yl acetate

C32H50O2 (466.3811)


   

(1r,3as,3bs,5r,5ar,7s,9r,9as,9bs,11ar)-1-[(2r,5s)-6-hydroxy-5,6-dimethylheptan-2-yl]-9a,11a-dimethyl-tetradecahydrocyclopenta[a]phenanthrene-5,5a,7,9-tetrol

(1r,3as,3bs,5r,5ar,7s,9r,9as,9bs,11ar)-1-[(2r,5s)-6-hydroxy-5,6-dimethylheptan-2-yl]-9a,11a-dimethyl-tetradecahydrocyclopenta[a]phenanthrene-5,5a,7,9-tetrol

C28H50O5 (466.3658)


   

(1r,3as,3bs,5r,5ar,7s,9ar,9bs,11ar)-1-[(2r,5s,6r)-6,7-dihydroxy-5,6-dimethylheptan-2-yl]-9a,11a-dimethyl-tetradecahydrocyclopenta[a]phenanthrene-5,5a,7-triol

(1r,3as,3bs,5r,5ar,7s,9ar,9bs,11ar)-1-[(2r,5s,6r)-6,7-dihydroxy-5,6-dimethylheptan-2-yl]-9a,11a-dimethyl-tetradecahydrocyclopenta[a]phenanthrene-5,5a,7-triol

C28H50O5 (466.3658)


   

2-{3a,6,6,9a,11a-pentamethyl-7-oxo-1h,2h,3h,5h,5ah,8h,9h,11h-cyclopenta[a]phenanthren-1-yl}-6-methyl-5-methylideneheptanoic acid

2-{3a,6,6,9a,11a-pentamethyl-7-oxo-1h,2h,3h,5h,5ah,8h,9h,11h-cyclopenta[a]phenanthren-1-yl}-6-methyl-5-methylideneheptanoic acid

C31H46O3 (466.3447)


   

1-(5,6-dihydroxy-5-isopropylhexan-2-yl)-9a,11a-dimethyl-tetradecahydro-1h-cyclopenta[a]phenanthrene-3,5,7-triol

1-(5,6-dihydroxy-5-isopropylhexan-2-yl)-9a,11a-dimethyl-tetradecahydro-1h-cyclopenta[a]phenanthrene-3,5,7-triol

C28H50O5 (466.3658)


   

2-[(1r,9as,11ar)-3a,6,6,9a,11a-pentamethyl-7-oxo-1h,2h,3h,5h,5ah,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-6-methyl-5-methylideneheptanoic acid

2-[(1r,9as,11ar)-3a,6,6,9a,11a-pentamethyl-7-oxo-1h,2h,3h,5h,5ah,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-6-methyl-5-methylideneheptanoic acid

C31H46O3 (466.3447)